No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 344,151 | 521,943 | 650,476 | 911,974 | 1,189,499 | 1,353,630 | 1,896,607 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 37,487 | 81,098 | 366,854 | 35,445 | 87,243 | 162,120 | 427,577 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
Similar companies
- Aditya Birla Capital Limited
- CNPC Capital Company Limited
- Storebrand ASA
- Power Financial Corporation
- Chailease Holding Company Limited
- Guangzhou Yuexiu Financial Holdings Group Co., Ltd.
- Brookfield Infrastructure Finance ULC 5 % Notes 2021-24.05.81 Global
- TPG Operating Group II, L.P. 6.950% Fixed-Rate Junior Subordinated Notes due 2064
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
SBI Holdings, Inc. (8473.T)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
- Aditya Birla Capital Limited
- CNPC Capital Company Limited
- Storebrand ASA
- Power Financial Corporation
- Chailease Holding Company Limited
- Guangzhou Yuexiu Financial Holdings Group Co., Ltd.
- Brookfield Infrastructure Finance ULC 5 % Notes 2021-24.05.81 Global
- TPG Operating Group II, L.P. 6.950% Fixed-Rate Junior Subordinated Notes due 2064
